SCHEMBL30734147

SCHEMBL30734147

O=C1CNCCN1c1ccccc1F

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.58
KMT2A Q03164 3/20 0.58
SCN9A Q15858 2/20 0.46
MGLL Q99685 1/20 0.41
ALDH1A1 P00352 2/20 0.40
KDM4E B2RXH2 1/20 0.40
CYP1A2 P05177 1/20 0.40
POLB P06746 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2D6 P10635 1/20 0.40
MAPT P10636 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
HTR7 P34969 1/20 0.40
P2RX7 Q99572 1/20 0.39
HTR1A P08908 3/20 0.38
SLC6A2 P23975 3/20 0.38
SLC6A4 P31645 3/20 0.38
SLC6A3 Q01959 2/20 0.38
NOTUM Q6P988 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1583869 1.00 MEN1 (0.58) MEN1KMT2ASCN9AMGLLALDH1A1
Hydrochloric Acid SCHEMBL1583713 0.98 MEN1 (0.56) MEN1KMT2ASCN9AMGLLALDH1A1
SCHEMBL1583486 0.87 MEN1 (0.42) MEN1KMT2ASCN9AHTR7P2RX7
SCHEMBL1583742 0.82 SLC6A2 (0.45) MEN1KMT2AP2RX7HTR1ASLC6A2
SCHEMBL1583680 0.82 P2RX7 (0.42) MEN1KMT2AP2RX7HTR1ASLC6A2
Hydrochloric Acid SCHEMBL1583969 0.81 P2RX7 (0.41) MEN1KMT2AP2RX7HTR1ASLC6A2
Hydrochloric Acid SCHEMBL1583930 0.81 SLC6A2 (0.44) MEN1KMT2AALDH1A1KDM4EP2RX7
SCHEMBL23064632 0.80 MGLL (0.41) MGLLP2RX7SLC6A2SLC6A4SLC6A3
SCHEMBL1814949 0.80 ADRB1 (0.56) MGLLP2RX7SLC6A2SLC6A4SLC6A3
SCHEMBL3653056 0.80 ADRB1 (0.54) MEN1KMT2AMGLLMAPTHTR7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250382301-A1 SMALL MOLECULE INHIBITORS OF DYRK/CLK AND USES THEREOF UNIV ARIZONA (US) 2025-12-18 US disclosed
EP-4543888-A1 SMALL MOLECULE INHIBITORS OF DYRK/CLK AND USES THEREOF Arizona Board of Regents on behalf of The University of Arizona (US) 2025-04-30 EP disclosed
WO-2023250083-A1 SMALL MOLECULE INHIBITORS OF DYRK/CLK AND USES THEREOF ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (US) 2023-12-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250382301-A1 SMALL MOLECULE INHIBITORS OF DYRK/CLK AND USES THEREOF CLK2, CLK3, CLK1 MEN1 407/4885KMT2A 2060/4885SCN9A 3753/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.